Skip to main content
SpringerLink
Log in

42/w mit auffälligem Befund in der rechten Brust

Vorbereitung auf die Facharztprüfung: Fall 19

42/f- with a suspicious finding in the right breast

Preparation for the specialist examination: case 19

  • Facharzt-Training
  • Published:
Der Gynäkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Rhiem K, Bücker-Nott HJ, Hellmich M et al (2019) Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort. Breast J 25(3):455–460. https://doi.org/10.1111/tbj.13257

    Article  PubMed  Google Scholar 

  2. Kast K, Rhiem K, Wappenschmidt B et al (2016) Prevalence of BRCA1/2 germline mutations in 21.401 families with breast and ovarian cancer. J Med Genet 53:465–471

    Article  CAS  Google Scholar 

  3. Engel C, Rhiem K, Hahnen E et al (2018) Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triplenegative breast cancer without family cancer history. BMC Cancer 18(1):265. https://doi.org/10.1186/s12885-018-4029-y

    Article  PubMed  PubMed Central  Google Scholar 

  4. Harter P, Hauke J, Heitz F et al (2017) Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR1). PLoS ONE 12:e186043

    Article  Google Scholar 

  5. Hauke J, Horvath J, Groß E et al (2018) Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancer Med. https://doi.org/10.1002/cam4.1376

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kuchenbaecker KB, Hopper JL, Barnes DR et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402–2416

    Article  CAS  Google Scholar 

  7. Engel C, Fischer C, Zachariae S, Bucksch K, Rhiem K, Giesecke J, Herold N, Wappenschmidt B, Hübbel V, Maringa M, Reichstein-Gnielinski S, Hahnen E, Bartram CR, Dikow N, Schott S, Speiser D, Horn D, Fallenberg EM, Kiechle M, Quante AS, Vesper AS, Fehm T, Mundhenke C, Arnold N, Leinert E, Just W, Siebers-Renelt U, Weigel S, Gehrig A, Wöckel A, Schlegelberger B, Pertschy S, Kast K, Wimberger P, Briest S, Loeffler M, Bick U, Schmutzler RK, German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC) (2020) Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance. Int J Cancer 146(4):999–1009. https://doi.org/10.1002/ijc.32396

    Article  CAS  PubMed  Google Scholar 

  8. Graeser MK, Engel C, Rhiem K et al (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27:5887–5892

    Article  Google Scholar 

  9. Rhiem K, Engel C, Graeser M et al (2012) The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study. Breast Cancer Res 14:R156

    Article  Google Scholar 

  10. Bick U, Engel C, Krug B et al (2019) High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer. Breast Cancer Res Treat 175:217–228

    Article  Google Scholar 

  11. Heemskerk-Gerritsen BA, Rookus MA, Aalfs CM et al (2015) Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. Int J Cancer 136(3):668–677

    CAS  PubMed  Google Scholar 

  12. Pierce LJ, Levin AM, Rebbeck TR et al (2006) Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2associated stage I/II breast cancer. J Clin Oncol 24(16):2437–2443

    Article  Google Scholar 

  13. Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975

    Article  CAS  Google Scholar 

  14. Heemskerk-Gerritsen BAM, Jager A, Koppert LB et al (2019) Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 177(3):723–733 (18)

    Article  CAS  Google Scholar 

  15. Mavaddat N, Antoniou AC, Mooij TM et al (2020) Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 22(1):8

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zentrum Familiärer Brust- und Eierstockkrebs, Universitätsklinikum Köln, Kerpener Str. 62, 50937, Köln, Deutschland

    K. Rhiem & R. K. Schmutzler

Authors
  1. K. Rhiem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. K. Schmutzler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Rhiem.

Ethics declarations

Interessenkonflikt

K. Rhiem und R.K. Schmutzler geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.

The supplement containing this article is not sponsored by industry.

Additional information

Redaktion

K. Diedrich, Hamburg

M. Friedrich, Krefeld

U. Gembruch, Bonn

W. Jonat, Kiel

A. Rody, Lübeck

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rhiem, K., Schmutzler, R.K. 42/w mit auffälligem Befund in der rechten Brust. Gynäkologe 53 (Suppl 1), 106–110 (2020). https://doi.org/10.1007/s00129-020-04675-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-020-04675-3

Schlüsselwörter

Keywords

Search

Navigation